期刊
IMMUNOTHERAPY
卷 12, 期 15, 页码 1101-1103出版社
FUTURE MEDICINE LTD
DOI: 10.2217/imt-2020-0205
关键词
anti-PD-1/PD-L1; COVID-19; immunosuppressed; immunotherapy; janus kinase inhibitors; pandemic; SARS-CoV-2; tocilizumab; virus